恒瑞医药(600276.SH)：硫酸艾玛昔替尼片、SHR0302碱凝胶获批临床试验

Core Viewpoint - Heng Rui Medicine (600276.SH) has received approval from the National Medical Products Administration for clinical trials of Sulfate Emamectin Benzoate Tablets and SHR0302 Gel, aimed at treating vitiligo [1] Group 1 - The company and its subsidiary, Ruishi Biopharmaceutical Co., Ltd., will soon initiate clinical trials for the approved drugs [1] - The indications for the drugs include the use of Sulfate Emamectin Benzoate Tablets alone or in combination with SHR0302 Gel for the treatment of vitiligo [1]